Cover Image
Market Research Report

Europe Clinical Nutrition Market Forecast 2019-2028

Published by Inkwood Research Product code 952508
Published Content info 119 Pages
Delivery time: 2-3 business days
Price
Back to Top
Europe Clinical Nutrition Market Forecast 2019-2028
Published: August 3, 2020 Content info: 119 Pages
Description

KEY FINDINGS

The Europe clinical nutrition market is evaluated to project a CAGR of 4.63%, during the forecast period of 2019 to 2028. The surging awareness among patients regarding the availability of clinical nutrition, and the increasing incidence of chronic diseases are predicted to accelerate the region's market growth.

MARKET INSIGHTS

The Europe clinical nutrition market is assessed across countries, namely, the United Kingdom, France, Russia, Italy, Germany, Poland, Belgium, and the rest of Europe. The market in France is expected to depict a steady demand for clinical nutrition, owing to solid consumer preferences, and the upsurge in precautionary measures, in view of the coronavirus pandemic. Moreover, the high prevalence of chronic diseases like diabetes, obesity, and heart diseases, incorporated with the country's growing geriatric population, is expected to drive the demand for clinical nutrition.

According to an EU Commission study, among each member state, France accounts for the highest number of people with chronic diabetes. Although obesity in the country is relatively lower than most of the Organization for Economic Cooperation and Development (OECD) countries, the rates are rising steadily. As a result, aligning with these estimations, one in ten citizens is obese, and nearly 40% are overweight, including obese. The OCED projections also depict that the overweight rates will crease by 10%, over the next decade. Thus, the prevalence of chronic conditions and the general awareness of the advantages of dietary supplements amid the COVID-19 pandemic, is predicted to bolster the market for clinical nutrition in the region.

COMPETITIVE INSIGHTS

Eminent companies in the market include, BASF SE, Nestle Health Science, Abbott Laboratories, Baxter International Inc, Danone, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 32932

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. INCREASING PREVALENCE OF CHRONIC DISEASES AND LIFESTYLE ASSOCIATED DISEASE
    • 3.2.2. RISE IN ELDERLY POPULATION
    • 3.2.3. HIGH OCCURRENCE OF MALNUTRITION AMONG HOSPITALIZED PATIENTS
  • 3.3. KEY RESTRAINTS
    • 3.3.1. LACK OF AWARENESS FOR CLINICAL NUTRITION
    • 3.3.2. COMPLICATIONS ASSOCIATED WITH ENTERAL FEEDING
    • 3.3.3. STRINGENT REGULATIONS

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCE ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. IMPACT OF COVID-19 ON CLINICAL NUTRITION MARKET
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE
  • 4.5. KEY INVESTMENT INSIGHTS

5. MARKET BY ROUTE OF ADMINISTRATION

  • 5.1. ORAL
  • 5.2. ENTERAL
  • 5.3. PARENTERAL

6. MARKET BY APPLICATION

  • 6.1. CANCER
  • 6.2. NEUROLOGICAL DISEASES
  • 6.3. GASTROINTESTINAL DISORDERS
  • 6.4. METABOLIC DISORDERS
  • 6.5. OTHER APPLICATIONS

7. MARKET BY END-USER

  • 7.1. PEDIATRIC
  • 7.2. GERIATRIC
  • 7.3. ADULTS

8. GEOGRAPHICAL ANALYSIS

  • 8.1. EUROPE
    • 8.1.1. GERMANY
    • 8.1.2. FRANCE
    • 8.1.3. THE UNITED KINGDOM
    • 8.1.4. ITALY
    • 8.1.5. RUSSIA
    • 8.1.6. BELGIUM
    • 8.1.7. POLAND
    • 8.1.8. REST OF EUROPE

9. COMPANY PROFILES

  • 9.1. ABBOTT LABORATORIES
  • 9.2. AMERICAN REGENT INC
  • 9.3. BASF SE
  • 9.4. BAXTER INTERNATIONAL INC
  • 9.5. B BRAUN
  • 9.6. DANONE
  • 9.7. EXELA PHARMA SCIENCES
  • 9.8. GRIFOLS SA
  • 9.9. LONZA LTD
  • 9.10. MEIJI HOLDINGS CO LTD
  • 9.11. NESTLE HEALTH SCIENCE
  • 9.12. OTSUKA HOLDINGS CO LTD
  • 9.13. RECKITT BENCKISER GROUP PLC
  • 9.14. SANOFI
  • 9.15. SICHUAN KELUN PHARMACEUTICAL CO LTD

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - CLINICAL NUTRITION
  • TABLE 2: EUROPE CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 3: EUROPE CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 4: EUROPE CLINICAL NUTRITION MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 5: EUROPE CLINICAL NUTRITION MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 6: EUROPE CLINICAL NUTRITION MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 7: EUROPE CLINICAL NUTRITION MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 8: EUROPE CLINICAL NUTRITION MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 9: EUROPE CLINICAL NUTRITION MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: MAJOR CATEGORIES OF EUROPE HEALTH SPENDING, 2017
  • FIGURE 2: COMPLICATIONS OF ENTERAL FEEDING
  • FIGURE 3: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 4: OPPORTUNITY MATRIX
  • FIGURE 5: VENDOR LANDSCAPE
  • FIGURE 6: KEY INVESTMENT INSIGHTS
  • FIGURE 7: EUROPE CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, IN 2019
  • FIGURE 8: EUROPE CLINICAL NUTRITION MARKET, BY ORAL, 2019-2028 (IN $ MILLION)
  • FIGURE 9: EUROPE CLINICAL NUTRITION MARKET, BY ENTERAL, 2019-2028 (IN $ MILLION)
  • FIGURE 10: EUROPE CLINICAL NUTRITION MARKET, BY PARENTERAL, 2019-2028 (IN $ MILLION)
  • FIGURE 11: EUROPE CLINICAL NUTRITION MARKET, BY APPLICATION, IN 2019
  • FIGURE 12: EUROPE CLINICAL NUTRITION MARKET, BY CANCER, 2019-2028 (IN $ MILLION)
  • FIGURE 13: EUROPE CLINICAL NUTRITION MARKET, BY NEUROLOGICAL DISEASES, 2019-2028 (IN $ MILLION)
  • FIGURE 14: EUROPE CLINICAL NUTRITION MARKET, BY GASTROINTESTINAL DISORDERS, 2019-2028 (IN $ MILLION)
  • FIGURE 15: EUROPE CLINICAL NUTRITION MARKET, BY METABOLIC DISORDERS, 2019-2028 (IN $ MILLION)
  • FIGURE 16: EUROPE CLINICAL NUTRITION MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $ MILLION)
  • FIGURE 17: EUROPE CLINICAL NUTRITION MARKET, BY END-USER, IN 2019
  • FIGURE 18: EUROPE CLINICAL NUTRITION MARKET, BY PEDIATRIC, 2019-2028 (IN $ MILLION)
  • FIGURE 19: EUROPE CLINICAL NUTRITION MARKET, BY GERIATRIC, 2019-2028 (IN $ MILLION)
  • FIGURE 20: EUROPE CLINICAL NUTRITION MARKET, BY ADULTS, 2019-2028 (IN $ MILLION)
  • FIGURE 21: EUROPE CLINICAL NUTRITION MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 22: GERMANY CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 23: FRANCE CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 24: THE UNITED KINGDOM CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 25: ITALY CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 26: RUSSIA CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 27: BELGIUM CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 28: POLAND CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 29: REST OF EUROPE CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
Back to Top